Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori

Table 3

Adverse events of RAK and RBAK therapies for Helicobacter pylori eradication.

Adverse events, n (%)	RAK ()	RBAK ()	value
Abdominal pain	9 (11.1)	12 (14.8)	0.48
Diarrhea	14 (17.3)	11 (13.6)	0.52
Constipation	3 (3.7)	4 (4.9)	0.70
Headache	3 (3.7)	1 (1.2)	0.31
Anorexia	1 (1.2)	1 (1.2)	—
Nausea	3 (3.7)	2 (2.5)	0.65
Skin rash	2 (2.5)	1 (1.2)	0.56
Dizziness	3 (3.7)	2 (2.5)	0.65
Bad taste	25 (30.9)	20 (24.7)	0.38
Fatigue	9 (11.1)	7 (8.6)	0.60
Others	7 (8.6)	15 (18.5)	0.07
Overall	41 (50.6)	41 (50.6)	—